177. Deputy Louise O'Reilly asked the Minister for Health further to parliamentary Question No. 93 of 1 December 2016, and in relation to the working group to bring forward appropriate decision criteria for the reimbursement of orphan medicines and technologies, the orphan medicines and technologies that will be considered; if there are any medicines earmarked that need to be evaluated under any new criteria developed; if the decision criteria will be open and transparent; the persons or bodies involved in the decision-making process; and if he will make a statement on the matter. [39211/16]

Summary

177. Deputy Louise O'Reilly asked the Minister for Health further to parliamentary Question No. 93 of 1 December 2016, and in relation to the working group to bring forward appropriate decision criteria for the reimbursement of orphan medicines and technologies, the orphan medicines and technologies that will be considered; if there are any medicines earmarked that need to be evaluated under any new criteria developed; if the decision criteria will be open and transparent; the persons or bodies involved in the decision-making process; and if he will make a statement on the matter. [39211/16]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Disease Management

  xml · EN · 8 December 2016

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.